Altitude Life Science Ventures

Portfolio Companies 2026 for Altitude Life Science Ventures: investors, rounds, and co-investor patterns from StartupFundraising.com research.

Altitude Life Science Ventures accounts for 12 tracked companies with verified cap-table data, 12 of which disclose round sizes totalling $3.2B. The median disclosed raise is $240M, and the largest is Sana Biotechnology at $700M, ahead of Neumora Therapeutics ($500M) and Vividion Therapeutics ($362M).

The names that recur most often on these portfolio cap tables are Altitude Life Science Ventures (12 companies), ARCH Venture Partners (6 companies), Alexandria Venture Investments (4 companies), Flagship Pioneering (3 companies), F-Prime Capital (2 companies), Baillie Gifford (2 companies). By latest disclosed round, the market skews Series A (4), Series B (2), Series D (2), Series C (2).

Best funded Altitude Life Science Ventures companies

  1. Sana Biotechnology — $700M (latest: IPO)
  2. Neumora Therapeutics — $500M (latest: Series A)
  3. Vividion Therapeutics — $362M (latest: Series B)
  4. Indigo AG — $300M (latest: Series D)
  5. Nuvation Bio — $275M (latest: Series A)
  6. Encoded Therapeutics — $240M (latest: Series D)
  7. Escient Pharmaceuticals — $238M (latest: Series C)
  8. Lila Sciences — $200M (latest: Seed)
  9. Omniome — $160M (latest: Series C)
  10. Ring Therapeutics — $117M (latest: Series B)
  11. Mozart Therapeutics — $80M (latest: Series A)
  12. Cero Therapeutics — $40M (latest: Series A)

Altitude Life Science Ventures — related firms and companies (56)

Altitude Life Science Ventures alternatives · All research reports